Johnson City Medical Center is a hospital in Johnson City, Tennessee. It is a Level I Trauma Center and one of three major tertiary referral hubs of regional provider Ballad Health. It has 445 beds, plus 86 in the attached Niswonger Children's Hospital.

There are 514 beds in Johnson City Medical Center.

During the past decade, Johnson City Medical Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Johnson City Medical Center" #1 sponsor was "Arginox Pharmaceuticals" with 1 trials, followed by "BHR Pharma, LLC" with 1 trials sponsored, "Faraday Pharmaceuticals, Inc." with 1 trials sponsored, "Intercept Pharmaceuticals" with 1 trials sponsored and "Mountain Home Research & Education Corporation" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Johnson City Medical Center" #1 collaborator was "Cubist Pharmaceuticals LLC" with 1 trials as a collaborator, "East Tennessee State University" with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Johnson City Medical Center" are "Acute Myocardial Infarction" (1 trials), "Brain Injuries" (1 trials), "Compensated Cirrhosis" (1 trials), "Hemorrhage" (1 trials) and "Hemorrhagic Shock" (1 trials). Many other conditions were trialed in "Johnson City Medical Center" in a lesser frequency.

Most popular intervention types in "Johnson City Medical Center" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Bentracimab (PB2452) Infusion" (1 trials), "Daptomycin" (1 trials), "FDY-5301" (1 trials) and "Lipid emulsion without progesterone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Johnson City Medical Center" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Johnson City Medical Center". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Johnson City Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Johnson City Medical Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".